Passage Bio Inc
NASDAQ:PASG
Passage Bio Inc
NASDAQ:PASG
Price:
8.08
USD
2.93%
Market Cap:
$25.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Passage Bio Inc
NASDAQ:PASG
|
US |
|
A
|
Argonaut Resources N L
OTC:AGREF
|
AU |
|
Mexedia SpA SB
PAR:ALMEX
|
IT |
|
W
|
Washington Real Estate Investment Trust
F:WRI
|
US |
|
Lisata Therapeutics Inc
NASDAQ:LSTA
|
US |
|
Aerovate Therapeutics Inc
NASDAQ:AVTE
|
US |
|
H
|
Hoegh Autoliners ASA
OSE:HAUTO
|
NO |
|
I
|
Intek Group SpA
F:MTJ3
|
IT |
Wall Street
Price Targets
PASG Price Targets Summary
Passage Bio Inc
Passage Bio Inc
Wall Street analysts forecast PASG stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
PASG
is 31.42 USD
with a low forecast of 10.1 USD and a high forecast of 71.4 USD.
Lowest
Price Target
10.1
USD
25% Upside
Average
Price Target
31.42
USD
289% Upside
Highest
Price Target
71.4
USD
784% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PASG's stock price target?
Price Target
31.42
USD
31.42
USD
According to Wall Street analysts, the average 1-year price target for
PASG
is 31.42 USD
with a low forecast of 10.1 USD and a high forecast of 71.4 USD.
